Markets:

Overview

News

Currencies

International

Treasuries

iShares Biotechnology ETF (NQ:IBB)

170.35 +0.24 (+0.14%)

Streaming Delayed Price Updated: 12:34 PM EST, Dec 2, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about iShares Biotechnology ETF

< Previous 1 2 3 4 5 6 7 8 9

...

27 28 Next >

Pay No Attention To That Tran Behind The Curtain? ↗

May 26, 2024

For the sake of redundancy and in case you are living under a rock and just came out to read my Daily, Nvidia (NVDA) and its ginormous beat on revenues, gave the market new life.

Via Talk Markets

Why the Rest of 2024 Could Be Good for Investing in Biotech Stocks ↗

May 24, 2024

Investors have been ignoring biotech stocks for far too long. Here's why they could start to heat up in 2024.

Via InvestorPlace

Large Cap Biopharmaceuticals Performance ↗

May 20, 2024

The biotech sector remains a laggard YTD as can be seen by the IBB.

Via Talk Markets

For Biotech Stocks To Move Higher, This Must Move Lower ↗

May 15, 2024

While biotechs have significantly lagged behind the broader market, there is reason to be optimistic once inflation-related volatility subsides. IBB and XBI present good vehicles for biotech exposure.

Via Talk Markets

Will the Biotech Sector Shift From Lagger to Leader?

May 10, 2024

The biotech sector has experienced a significant rally after bouncing off uptrend support and is now consolidating near major SMAs.

Via MarketBeat

Topics ETFs

Consumer Spending - Single Most Driving Force ↗

May 07, 2024

The choices we make as consumers collectively shape the economic landscape, and our spending patterns influence the well-being of our communities and the nation.

Via Talk Markets

Economic Modern Family-Tell Us a Story ↗

May 05, 2024

Taking a look at the markets and how to best prepare for the coming week.

Via Talk Markets

When Silver Looks Bad, It’s Been A Sign Of A Bottom ↗

April 30, 2024

Silver cleared $26 but for only 3 weeks. Then it gapped lower in early May 2023 and did not clear that level ($26) again for a year.

Via Talk Markets

Can Semiconductors Pull Off Another Sustained Rally? ↗

April 28, 2024

With all the news flying around, we have found incredible confidence in our trading strategies by following the technical picture.

Via Talk Markets

Quick Look At The Economic Modern Family ↗

April 23, 2024

While I am extremely focused on commodities as outlined in Monday’s Daily, my viewpoint for most equities remains cautious to neutral. What might turn us to be more bullish? Let’s analyze.

Via Talk Markets

April Showers On Wall Street: Miners, Utilities Emerge As Bright Spots In Gloomy Market ↗

April 30, 2024

Performance in April 2024: Utilities lead, real estate lags. S&P 500, Nasdaq 100, Dow Jones Industrial Average, small-cap and large-cap indices all decline.

Via Benzinga

Topics Stocks

Healthcare Stocks Are Lagging With Big Earnings Weeks Ahead ↗

April 16, 2024

Healthcare stocks disappointed again last week with the XLV down over 3% and up only 1.65 % YTD, in a continued downtrend since March 28.

Via Talk Markets

Massive Weekly Price Consolidation Will Show The Way ↗

April 08, 2024

Consolidation is one of our favorite chart patterns, especially when prices are consolidating at new highs or lows. The direction the price follows, up or down out of the consolidation can lead to...

Via Talk Markets

Rangebound Major Secor ETFs - What’s Next? ↗

April 04, 2024

Watching certain instruments for clues on the next moves, probably the best (equities) to watch is the major sector ETFs.

Via Talk Markets

Topics ETFs

Biotech Sector Nears Breakout: Will it Outperform in Q2?

April 03, 2024

The Biotech sector ETF is consolidating in its upper range, indicating a potential sector breakout despite modest year-to-date gains

Via MarketBeat

Topics ETFs

5 Healthcare Stocks to Buy for 2024 ↗

April 02, 2024

Healthcare stocks have been some of the top performers in 2024, and thanks to the potential of AI, these names will just keep heating up.

Via InvestorPlace

Topics Artificial Intelligence

Healthcare And Biotech Stocks Review: Q1 2024 Performance ↗

April 01, 2024

We just had one of the best first quarters in recent market history since Q1 in 2019 when the market was up 13%. But changes in sector performance may be coming. The S&P 500 was up 10% showing a slight...

Via Talk Markets

Topics Stocks

2 Top Biotech Buyout Candidates ↗

March 31, 2024

Investors who are adventurous, have a high-risk tolerance, and are home run hitters may opt for biotech stocks. Investors in this group may want to hone in on stocks that have the potential to be...

Via Talk Markets

3 Biotech Stocks That Could Be Multibaggers in the Making: March Edition ↗

March 28, 2024

Discover these three biotech stocks set for major gains with groundbreaking health solutions. Invest in the future of medicine.

Via InvestorPlace

Tuesday Talk: Big-Tech Under Attack ↗

March 26, 2024

On Thursday the Justice Dept. filed an antitrust suit against Apple. The suit joins two others already filed against Google. How much this will affect the market in the long run is up for grabs.

Via Talk Markets

Biotechnology And Healthcare, A Bit Of A Lull ↗

March 25, 2024

Strong momentum of Tech and Chip stocks may be too good of a distraction for biotech investors.

Via Talk Markets

Healthcare And Biotech Update With Market At 2024 Highs ↗

March 20, 2024

The bull market is intact with technology Stocks dominating, but XLV is up 6.89%YTD.

Via Talk Markets

3 Biotech ETFs Overdue for a Bounce ↗

March 19, 2024

The biotech ETFs have been under serious pressure in recent years. Newfound momentum and looming lower rates could spark a comeback.

Via InvestorPlace

Topics ETFs

Millionaire Makers: 3 Sectors Poised for 20X Gains ↗

March 18, 2024

Dive into three explosive sectors that could yield 20X returns for the bold investor. Uncover these potential millionaire makers.

Via InvestorPlace

Biotechs on the Rise: 3 Stocks to Buy for a Shot of Profits ↗

March 04, 2024

Given recent industry performance, the enthusiasm investors have for biotech stocks to buy is low. But these three companies seem promising.

Via InvestorPlace

3 Under-the-Radar Biotech Stocks With Upcoming Catalysts in 2024 ↗

February 26, 2024

Find out which under-the-radar biotech stocks have major catalysts on the horizon, and unlock their explosive growth potential.

Via InvestorPlace

Lottery Preference And Biotech Stocks: Trust The Financials, Not The Science ↗

February 25, 2024

Making a bet on biotech/pharma firms that have not yet achieved significant revenue is the equivalent of buying a lottery ticket—with the same poor risk/return relationship.

Via Talk Markets

Healthcare Stocks Are Looking Better But What About Biotech? ↗

February 20, 2024

Large cap biopharmacuiticals remain a core holding for growth and value despite political cross-currents on drug pricing.

Via Talk Markets

Has The Solar ETF TAN Bottomed? ↗

February 07, 2024

The last swing high before the huge parabolic move in TAN in 2020 was exactly where the current price was.

Via Talk Markets

Topics ETFs

The Transportation Sector Has A Story To Tell ↗

February 05, 2024

With the market experiencing a dose of reality on interest rates, we still believe that current rates are not the worst news for the market, depending on where you look.

Via Talk Markets

< Previous 1 2 3 4 5 6 7 8 9

...

27 28 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.